Stem cells and clinical trials: the current status and future perspectives

Article information

J Korean Med Assoc. 2011;54(5):448-449

Publication date (electronic) : 2011 May 11

doi : https://doi.org/10.5124/jkma.2011.54.5.448

¹Department of Physiology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

²Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

³Stem Cell Research Center, Seoul, Korea.

Corresponding author: Dong-Wook Kim, dwkim2@yuhs.ac

Received 2011 April 21; Accepted 2011 April 28.

References

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998. 2821145–1147.

2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006. 126663–676.

Article information Continued

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.